• MJHLS Brand Logo

© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Practice

Biosimilar Uptake Implies Patient Access to Affordable Medication

April 28th 2017

By The Center for Biosimilars Staff

Article

Who Will Influence Biosimilar Uptake: Physician, Pharmacist, Patient, or Payer?

April 27th 2017

By Carole Ellis

Article

Proposed Xolair Biosimilar Gets FDA Approval for Clinical Trials

April 26th 2017

By Jackie Syrop

Article

EMA Recommends 9 New Medicines, Including Biosimilars

April 25th 2017

By Jackie Syrop

Article

Dr Joseph P Fuhr Sees Need for Education Programs on Biosimilars

April 24th 2017

By The Center for Biosimilars Staff

Article

Patients' Reluctance to Accept Biosimilars Suggests Need for Better Communication, Education

April 20th 2017

By Jackie Syrop

Article

Nebraska Legislature Debates Biosimilar Substitution Bill

April 18th 2017

By Christina Mattina

Article

Prescribers in England Turn to Biosimilar Growth Hormones for Ease of Use, Not Cost

April 14th 2017

By Christina Mattina

Article

Humira Not Cost Effective for RA, ICER Report Concludes

April 11th 2017

By Jackie Syrop

Article

Sandoz Brief Addresses US Supreme Court in Case Against Amgen

April 7th 2017

By Jackie Syrop

Article